Your team

Meet the Team Behind This Evidence Review

Four physicians staff the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Dr. Tongchun Mao is the responsible physician for this evidence review; the Center Director guarantees the standards the practice is held to, and the medical and dermatologic members of the team carry the assessment of a capsule, a contour change or a skin problem around an implant.

Specialist profiles

Who reviews this content

Tongchun Mao

Tongchun Mao (毛彤春)

Deputy Director & Head of Aesthetic Surgery · Vice Chief Physician, Licensed Aesthetic Attending · Lead Physician of This Site

Breast implant assessment · surveillance and imaging pathways · removal and revision

Dr. Tongchun Mao is an aesthetic surgeon at Chongqing West District Hospital, where he is Deputy Director and Head of Aesthetic Surgery in its Plastic Surgery & Aesthetics Medical Center and the responsible physician for this site. He personally performs more than 700 operations a year, within hospital standards of assessment, anaesthesia and follow-up.

On this review his part is the distinction between what a study can show and what a patient is being told. He works from the evidence and the labelling rather than from a preference between devices, describes the surface, fill and shape differences as the real but limited differences they are, and treats the systemic question as unresolved rather than resolving it by tone in either direction. Where a person has an implant and no symptoms, he treats surveillance as a plan rather than as a delay, and where removal is being considered he is explicit that it is an endpoint a person may reach rather than a cure for anything. He documents what was implanted and when, because a record is what makes surveillance and any later assessment possible.

Clinical focus

  • Assessment of an existing implant: capsule, contour and the reason for surveillance
  • Surveillance pathways over time, and what imaging can and cannot show
  • Removal and revision, including removal without replacement
  • Reading a device claim against the evidence and the labelling behind it
  • Documentation of what was implanted and when, for whoever assesses it later

Association is not cause, and unresolved is not settled

A registry signal and a controlled study are different kinds of evidence, and only the second can establish that one thing causes another. Where the evidence is observational, this review says so and leaves the question open — because a reader who is told that the answer is not yet known can weigh the uncertainty, and a reader who is given false confidence in either direction cannot.

Shaoliang Wang

Shaoliang Wang (王韶亮)

Director, Plastic Surgery & Aesthetics Medical Center · Vice Chief Physician, Associate Professor, Doctor of Medicine

Center leadership and multidisciplinary case review

Dr. Shaoliang Wang is Director of the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team he provides the surgical perspective and the tertiary-hospital backstop — the assessment when an operation is the honest answer, and the hospital-level care for the rare complication that needs it.

Within the team, Shaoliang Wang contributes to the shared assessment of cases on this site.

Clinical focus

  • Center leadership and multidisciplinary case review
  • Surgical assessment when an operation is the honest answer to descent or excess skin
  • Hospital-based care for the rare complication that needs theatre-level management
Ke He

Ke He (何锞)

Deputy Director & Head of Skin & Laser Aesthetics · Attending Physician, Licensed Aesthetic Attending

Device and injectable assessment before any treatment plan

Dr. Ke He is Deputy Director and head of skin and laser aesthetics within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team her role is the device and injectable assessment, and the honest referral when a problem needs an operation rather than a needle.

Within the team, Ke He contributes to the shared assessment of cases on this site.

Clinical focus

  • Device and injectable assessment before any treatment plan
  • Staged planning judged against standardised photographs
  • Honest referral when a problem needs an operation rather than a needle
Yongbo Jia

Yongbo Jia (贾勇波)

Deputy Director & Head of Dermatology · Vice Chief Physician, Licensed Aesthetic Attending

Medical skin assessment behind injectable treatment plans

Dr. Yongbo Jia is a dermatologist within the Plastic Surgery & Aesthetics Medical Center at Chongqing West District Hospital. Within the team his role is medical skin assessment — diagnosing and managing pigment and barrier conditions, and treating skin that a device or an injection has irritated.

Within the team, Yongbo Jia contributes to the shared assessment of cases on this site.

Clinical focus

  • Medical skin assessment behind injectable treatment plans
  • Diagnosis and management of pigment and barrier conditions
  • Dermatologic care of skin after irritation or a delayed reaction

A question about the implant evidence?

This site is an evidence review rather than a booking page, and it does not recommend for or against any operation or offer an assessment in relation to anything it describes. If you have a question about this review, or about your own care, contact the team and ask.

Contact the Team